Literature DB >> 20107863

Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.

Anja Wilmes1, Pisana Rawson, Lifeng Peng, Danyl McLauchlan, Peter T Northcote, T William Jordan, John H Miller.   

Abstract

Peloruside A, isolated from the marine sponge Mycale hentscheli, has a similar mechanism of action to paclitaxel (Taxol®), a drug used clinically to treat tumors of the breast, ovary and lung. Paclitaxel and peloruside stabilize the polymerized form of tubulin and arrest cells in G₂/M of the cell cycle. We have therefore used two-dimensional electrophoresis of proteins to examine the effect of peloruside A on the human HL-60 promyeloid leukemic cell line. Our goals included investigation whether affected proteins could be mapped onto pathways that predicted the cellular effects of this compound. In response to 100 nM peloruside A treatment for 24 h, seventeen identified proteins showed significant change in abundance with fourteen increases and three decreases. Use of Ingenuity Pathways Analysis confirmed that peloruside A affected pathways consistent with the known effects on microtubules and apoptosis. Our results also indicate a potential role of c-Myc in the cellular actions of peloruside consistent with an induction of aneuploidy seen at low concentrations of peloruside.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107863     DOI: 10.1007/s10637-010-9387-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  45 in total

1.  Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations.

Authors:  Nicole M Verrills; Bradley J Walsh; Gary S Cobon; Peter G Hains; Maria Kavallaris
Journal:  J Biol Chem       Date:  2003-08-29       Impact factor: 5.157

2.  Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.

Authors:  R-H Yuan; Y-M Jeng; H-L Chen; P-L Lai; H-W Pan; F-J Hsieh; C-Y Lin; P-H Lee; H-C Hsu
Journal:  J Pathol       Date:  2006-08       Impact factor: 7.996

3.  c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.

Authors:  Antje Menssen; Alexey Epanchintsev; Dmitri Lodygin; Nousin Rezaei; Peter Jung; Berlinda Verdoodt; Joachim Diebold; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-02-03       Impact factor: 4.534

4.  MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Authors:  Giuliana Gatti; Giovanna Maresca; Manuela Natoli; Fulvio Florenzano; Angelo Nicolin; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

5.  A unique mode of microtubule stabilization induced by peloruside A.

Authors:  J Torin Huzil; John K Chik; Gordon W Slysz; Holly Freedman; Jack Tuszynski; Richard E Taylor; Dan L Sackett; David C Schriemer
Journal:  J Mol Biol       Date:  2008-03-19       Impact factor: 5.469

6.  Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages.

Authors:  Kevin P Crume; John H Miller; Anne C La Flamme
Journal:  Exp Biol Med (Maywood)       Date:  2007-05

7.  Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5.

Authors:  Frank Kozielski; Dimitrios A Skoufias; Rose-Laure Indorato; Yasmina Saoudi; Peter R Jungblut; Hanne K Hustoft; Margarita Strozynski; Bernd Thiede
Journal:  Proteomics       Date:  2008-01       Impact factor: 3.984

8.  Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.

Authors:  Kylie A Hood; Lyndon M West; Berber Rouwé; Peter T Northcote; Michael V Berridge; St John Wakefield; John H Miller
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

9.  Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform.

Authors:  Timothée Revil; Jordan Pelletier; Johanne Toutant; Alexandre Cloutier; Benoit Chabot
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

10.  Expression of beta-tubulin isotypes in human primary ovarian carcinoma.

Authors:  Yoshihiro Ohishi; Yoshinao Oda; Yuji Basaki; Hiroaki Kobayashi; Norio Wake; Michihiko Kuwano; Masazumi Tsuneyoshi
Journal:  Gynecol Oncol       Date:  2007-03-06       Impact factor: 5.482

View more
  4 in total

1.  Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.

Authors:  Ariane Chan; A Jonathan Singh; Peter T Northcote; John H Miller
Journal:  Invest New Drugs       Date:  2015-03-31       Impact factor: 3.850

2.  Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells.

Authors:  Ariane Chan; A Jonathan Singh; Peter T Northcote; John H Miller
Journal:  Invest New Drugs       Date:  2016-05-07       Impact factor: 3.850

3.  Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

Authors:  Anja Wilmes; Ariane Chan; Pisana Rawson; T William Jordan; John Holmes Miller
Journal:  Invest New Drugs       Date:  2010-09-23       Impact factor: 3.850

Review 4.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.